ANI PHARMACEUTICALS, INC Investment Income, Interest
ANI PHARMACEUTICALS, INC (ANIP) reported Investment Income, Interest of $1.86 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2013-05-10
- ANI PHARMACEUTICALS, INC investment income, interest for the quarter ending 2013-03-31 was $1.86K, a 6.63% decline year-over-year.
- ANI PHARMACEUTICALS, INC investment income, interest for the quarter ending 2012-12-31 was $3.24K, a 74.70% increase year-over-year.
- ANI PHARMACEUTICALS, INC investment income, interest for the quarter ending 2012-09-30 was $1.88K, a 23.81% increase year-over-year.
- ANI PHARMACEUTICALS, INC investment income, interest for the quarter ending 2012-06-30 was $1.43K, a 16.36% decline year-over-year.
- ANI PHARMACEUTICALS, INC investment income, interest for fiscal 2012 was $8.54K, a 2.56% increase from fiscal 2011.
- ANI PHARMACEUTICALS, INC investment income, interest for fiscal 2011 was $8.33K, a 34.26% decline from fiscal 2010.
- ANI PHARMACEUTICALS, INC investment income, interest for fiscal 2010 was $12.66K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2013-03-31 | $1.86K 10-Q · filed 2013-05-10 | $5.10K derived: sum of 2 quarters · filed 2013-05-10 | $6.98K derived: sum of 3 quarters · filed 2013-05-10 | $8.41K derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-12-31 | $3.24K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $5.12K derived: sum of 2 quarters · filed 2013-02-28 | $6.55K derived: sum of 3 quarters · filed 2013-02-28 | $8.54K 10-K · filed 2013-02-28 |
| 2012-09-30 | $1.88K 10-Q · filed 2012-11-08 | $3.31K derived: sum of 2 quarters · filed 2012-11-08 | $5.30K 10-Q · filed 2012-11-08 | $7.15K derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-06-30 | $1.43K 10-Q · filed 2012-08-01 | $3.42K 10-Q · filed 2012-08-01 | $5.28K derived: sum of 3 quarters · filed 2013-05-10 | $6.79K derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-03-31 | $1.99K 10-Q · filed 2013-05-10 | $3.85K derived: sum of 2 quarters · filed 2013-05-10 | $5.36K derived: sum of 3 quarters · filed 2013-05-10 | $7.07K derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $1.85K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.37K derived: sum of 2 quarters · filed 2013-02-28 | $5.08K derived: sum of 3 quarters · filed 2013-02-28 | $8.33K 10-K · filed 2013-02-28 |
| 2011-09-30 | $1.52K 10-Q · filed 2012-11-08 | $3.23K derived: sum of 2 quarters · filed 2012-11-08 | $6.47K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $1.71K 10-Q · filed 2012-08-01 | $4.96K 10-Q · filed 2012-08-01 | ||
| 2011-03-31 | $3.25K 10-Q · filed 2012-05-08 | |||
| 2010-12-31 | $12.66K 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $11.65K 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |